Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dolutegravir Expanded Access Study (DEAP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by ViiV Healthcare
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare
ClinicalTrials.gov Identifier:
NCT01536873
First received: February 16, 2012
Last updated: November 15, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)